These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3040498)
1. Binding of vasoactive intestinal polypeptide to dispersed enterocytes results in rapid removal of the NH2-terminal histidyl residue. Nau R; Ballmann M; Conlon JM Mol Cell Endocrinol; 1987 Jul; 52(1-2):97-103. PubMed ID: 3040498 [TBL] [Abstract][Full Text] [Related]
2. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine. Calvo JR; Couvineau A; Guijarro L; Laburthe M Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439 [TBL] [Abstract][Full Text] [Related]
4. Binding and internalization of VIP in rat intestinal epithelial cells. Izzo RS; Scipione RA; Pellecchia C; Lokchander RS Regul Pept; 1991 Mar; 33(1):21-30. PubMed ID: 1646466 [TBL] [Abstract][Full Text] [Related]
5. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line. Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033 [TBL] [Abstract][Full Text] [Related]
6. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes. Robichon A; Marie JC Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793 [TBL] [Abstract][Full Text] [Related]
7. Epithelial cells purified from choroid plexus have receptors for vasoactive intestinal polypeptide. Nilsson C; Fahrenkrug J; Lindvall-Axelsson M; Owman C Brain Res; 1991 Mar; 542(2):241-7. PubMed ID: 1851455 [TBL] [Abstract][Full Text] [Related]
8. Effect of bilateral adrenalectomy on VIP receptor/effector system in rat intestinal epithelial cells. Fernández-Moreno MD; Carrero I; Arilla E; Prieto JC Biosci Rep; 1990 Apr; 10(2):165-71. PubMed ID: 2162701 [TBL] [Abstract][Full Text] [Related]
9. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium. Elgavish A; Pillion DJ; Meezan E Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697 [TBL] [Abstract][Full Text] [Related]
10. Effect of gastroduodenostomy on intestinal vasoactive intestinal peptide (VIP) levels, and VIP binding and VIP stimulation of cyclic AMP in intestinal epithelial cells from rat. Carmena MJ; Prieto JC; Arilla E; Cacicedo L Biochem Med Metab Biol; 1987 Jun; 37(3):307-13. PubMed ID: 2440464 [TBL] [Abstract][Full Text] [Related]
11. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa. Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848 [TBL] [Abstract][Full Text] [Related]
12. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle. Chakder S; Rattan S J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560 [TBL] [Abstract][Full Text] [Related]
13. Lindane effect upon the vasoactive intestinal peptide receptor/effector system in rat enterocytes. Carrero I; Fernández-Moreno MD; Pérez-Albarsanz MA; Prieto JC Biochem Biophys Res Commun; 1989 Mar; 159(3):1391-6. PubMed ID: 2467674 [TBL] [Abstract][Full Text] [Related]
14. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
15. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites. Martin JM; Luis J; Marvaldi J; Pichon J; Pic P Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331 [TBL] [Abstract][Full Text] [Related]
16. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives. Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143 [TBL] [Abstract][Full Text] [Related]
17. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver. Chastre E; Emami S; Rosselin G; Gespach C Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182 [TBL] [Abstract][Full Text] [Related]
18. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells. Broyart JP; Dupont C; Laburthe M; Rosselin G J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191 [TBL] [Abstract][Full Text] [Related]
19. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site. Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330 [TBL] [Abstract][Full Text] [Related]
20. PACAP and VIP receptors in rat liver membranes. Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]